Freeman Lab lauded for catalyzing SARS-CoV-2 Research

Funded by RCSA’s swift COVID-19 response, the biomolecular engineering expertise at the Freeman Lab is being lauded as a catalyzing project. Resulting from this award, the Freeman Lab has “developed, patented, and quickly brought to mass-market production a glycopolymer-based lateral flow assay for detecting SARS-CoV-2 and its rapidly emerging variants”. The COVID-19 Initiative is a collaboration between Ronit Freeman of Freeman Lab, Rommie Amaro of the University of California, San Diego, and Carlos Simmerling of Stony Brook University. Read the full story here.